13F HOLDINGS REPORT
Tri Locum Partners LP
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001826434-24-000004
Total Value
$288.4M
Positions
27
Other Managers
0
Confidential Omitted
No
Holdings (27)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TEVA PHARMACEUTICAL INDS LTD | 881624209 | 2,216,188 | $31.3M | 10.84% |
| 2 | AVADEL PHARMACEUTICALS PLC | 05337M104 | 1,189,511 | $20.1M | 6.97% |
| 3 | SILK RD MED INC | 82710M100 | 1,083,605 | $19.9M | 6.88% |
| 4 | NATERA INC | NTRA | 190,114 | $17.4M | 6.03% |
| 5 | ASCENDIS PHARMA A/S | ASND | 112,670 | $17.0M | 5.91% |
| 6 | LEGEND BIOTECH CORP | LEGN | 283,773 | $15.9M | 5.52% |
| 7 | MERCK & CO INC | MRK | 119,200 | $15.7M | 5.45% |
| 8 | VERTEX PHARMACEUTICALS INC | VRTX | 35,598 | $14.9M | 5.16% |
| 9 | MADRIGAL PHARMACEUTICALS INC | MDGL | 53,355 | $14.2M | 4.94% |
| 10 | BAXTER INTL INC | 071813109 | 317,566 | $13.6M | 4.71% |
| 11 | MERUS N V | N5749R100 | 286,322 | $12.9M | 4.47% |
| 12 | TANDEM DIABETES CARE INC | TNDM | 326,506 | $11.6M | 4.01% |
| 13 | ARGENX SE | ARGX | 27,981 | $11.0M | 3.82% |
| 14 | XENON PHARMACEUTICALS INC | XENE | 207,465 | $8.9M | 3.10% |
| 15 | REGENERON PHARMACEUTICALS | REGN | 8,567 | $8.2M | 2.86% |
| 16 | AXSOME THERAPEUTICS INC | AXSM | 102,711 | $8.2M | 2.84% |
| 17 | PRAXIS PRECISION MEDICINES I | PRAX | 106,494 | $6.5M | 2.25% |
| 18 | EXACT SCIENCES CORP | 30063P105 | 90,000 | $6.2M | 2.16% |
| 19 | LYRA THERAPEUTICS INC | LYRA | 978,793 | $6.1M | 2.11% |
| 20 | ASTRIA THERAPEUTICS INC | 04635X102 | 369,549 | $5.2M | 1.80% |
| 21 | INSPIRE MED SYS INC | 457730109 | 23,566 | $5.1M | 1.76% |
| 22 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 120,687 | $4.8M | 1.66% |
| 23 | ARCTURUS THERAPEUTICS HLDGS | ARCT | 138,927 | $4.7M | 1.63% |
| 24 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 449,694 | $4.5M | 1.55% |
| 25 | MIND MEDICINE MINDMED INC | 60255C885 | 379,596 | $3.6M | 1.24% |
| 26 | PERSPECTIVE THERAPEUTICS INC | CATX | 780,303 | $928,561 | 0.32% |
| 27 | FEMASYS INC | FEMY | 30,606 | $47,439 | 0.02% |